At the time of writing, Incyte Corp [INCY] stock is trading at $75.45, up 0.87%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The INCY shares have gain 6.19% over the last week, with a monthly amount glided 2.51%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Incyte Corp [NASDAQ: INCY] stock has seen the most recent analyst activity on October 29, 2024, when BofA Securities upgraded its rating to a Buy and also boosted its price target to $90 from $68. Previously, Wolfe Research started tracking the stock with Outperform rating on October 01, 2024, and set its price target to $84. On September 18, 2024, downgrade downgraded it’s rating to Hold and revised its price target to $74 on the stock. BMO Capital Markets downgraded its rating to a Underperform and decreased its price target to $48 on July 02, 2024. Deutsche Bank initiated its recommendation with a Hold and recommended $55 as its price target on May 23, 2024. In a note dated February 23, 2024, Jefferies initiated an Buy rating and provided a target price of $81 on this stock.
For the past year, the stock price of Incyte Corp fluctuated between $50.35 and $83.95. Currently, Wall Street analysts expect the stock to reach $84.56 within the next 12 months. Incyte Corp [NASDAQ: INCY] shares were valued at $75.45 at the most recent close of the market. An investor can expect a potential return of 12.07% based on the average INCY price forecast.
Analyzing the INCY fundamentals
According to Incyte Corp [NASDAQ:INCY], the company’s sales were 4.08B for trailing twelve months, which represents an 23.81% jump. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.01 and Total Capital is -0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 74.75 points at the first support level, and at 74.06 for the second support level. However, for the 1st resistance point, the stock is sitting at 76.14, and for the 2nd resistance point, it is at 76.84.
Ratios To Look Out For
It is important to note that Incyte Corp [NASDAQ:INCY] has a current ratio of 1.87. Also, the Quick Ratio is 1.82, while the Cash Ratio stands at 0.87. Considering the valuation of this stock, the price to sales ratio is 3.60, the price to book ratio is 4.59 and price to earnings (TTM) ratio is 534.35.
Transactions by insiders
Recent insider trading involved Flannelly Barry P, EVP & General Manager US, that happened on Nov 06 ’24 when 3680.0 shares were sold. Officer, BARRY FLANNELLY completed a deal on Nov 06 ’24 to buy 3680.0 shares. Meanwhile, Principal Accounting Officer Tray Thomas sold 572.0 shares on Sep 12 ’24.
